Biotech Vaneck Etf Analysis

BBH -  USA Etf  

USD 195.40  1.21  0.62%

The modest gains experienced by current holders of Biotech Vaneck could raise concerns from stockholders as the entity it trading at a share price of 195.40 on 12,266 in volume. The fund executives have been quite successful in maneuvering the etf at opportune times to take advantage of all market conditions in May. The etf standard deviation of daily returns for 90 days investing horizon is currently 1.35. The below-average Etf volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Continue to Trending Equities.

Search Etf Analysis 

 
Refresh
The Biotech Vaneck etf analysis report makes it easy to digest most publicly released information about Biotech Vaneck and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Biotech stock analysis module also helps to analyze the Biotech Vaneck price relationship with some important fundamental indicators such as market cap and management efficiency.

Biotech Etf Analysis Notes

Biotech Vaneck is is formed as Regulated Investment Company in the United States. ETF is managed and operated by Van Eck Associates Corporation. The fund has 26 constituents with avarage daily trading value of 17.6 K. The fund charges 0.35 percent management fee with total expences of 0.39 percent of total asset. The fund generated five year return of 14.0%. Biotech Vaneck ETF holds all of assets under management (AUM) in equities. This fund last dividend was 0.472 per share. The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. Biotech Vaneck is traded on NYSEArca Exchange in the United States. For more info on Biotech Vaneck ETF please contact the company at 800-826-2333.

Sector Exposure (%)

Investment Allocations (%)

Biotech Vaneck ETF Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biotech Vaneck's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biotech Vaneck ETF or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Biotech Vaneck ETF is unlikely to experience financial distress in the next 2 years
The fund holds all of its assets under management (AUM) in equities

Biotech Vaneck Thematic Classifications

In addition to having Biotech Vaneck etf in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.

Biotech Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Biotech Vaneck is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biotech Vaneck ETF backward and forwards among themselves. Biotech Vaneck's institutional investor refers to the entity that pools money to purchase Biotech Vaneck's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Group One Trading LpPut Options2.5 M82.3 M
Group One Trading LpCall Options2.3 M75.1 M
Goldman Sachs Group IncFund Units119.4 K21 M
Note, although Biotech Vaneck's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Management Efficiency

Biotech Vaneck management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Top Etf Constituents

Information
Ratio
Value
At Risk
BGNE
Beigene Ltd Ads 0.0013 (4.36) 
ILMN
Illumina 0.0469 (2.60) 
VRTX
Vertex Pharmaceutic(0.16) (1.72) 
SGEN
Seagen Inc 0.0161 (3.25) 
REGN
Regeneron Pharmaceuticals 0.08 (2.25) 
NVAX
Novavax(0.0268) (9.94) 
MRNA
Moderna 0.11 (6.19) 
IQV
Iqvia Holdings 0.30 (1.24) 
INCY
Incyte Corp 0.0116 (2.23) 
IMMU
Immunomedics, 0.13 (2.93) 
GILD
Gilead Sciences 0.0291 (1.66) 
GH
Guardant Health(0.09) (5.21) 
EXAS
Exact Sciences Cor(0.0152) (4.90) 
BMRN
Biomarin Pharmaceuticals 0.05 (1.94) 
BIIB
Biogen Inc 0.13 (2.20) 
AMGN
Amgen Inc(0.0247) (1.86) 
ALXN
Alexion Pharm 0.21 (1.05) 

Institutional Etf Holders for Biotech Vaneck

Technical Drivers

As of the 20th of June, Biotech Vaneck shows the Mean Deviation of 1.05, risk adjusted performance of 0.0725, and Downside Deviation of 1.39. Biotech Vaneck ETF technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices. Put another way, you can use this information to find out if the entity will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Biotech Vaneck ETF, which can be compared to its rivals. Please confirm Biotech Vaneck ETF maximum drawdown, and the relationship between the information ratio and downside variance to decide if Biotech Vaneck ETF is priced correctly, providing market reflects its regular price of 195.4 per share.

Biotech Vaneck ETF Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. View also all equity analysis or get more info about mavp overlap studies indicator.

Biotech Vaneck Technical and Predictive Indicators

Biotech Vaneck Forecast Models

Biotech Vaneck time-series forecasting models is one of many Biotech Vaneck's etf analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotech Vaneck's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Biotech Vaneck Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biotech Vaneck stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotech shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Biotech Vaneck. By using and applying Biotech Etf analysis, traders can create a robust methodology for identifying Biotech entry and exit points for their positions.
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biotech Vaneck to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module
Continue to Trending Equities. Note that the Biotech Vaneck ETF information on this page should be used as a complementary analysis to other Biotech Vaneck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Biotech Vaneck Etf analysis

When running Biotech Vaneck ETF price analysis, check to measure Biotech Vaneck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Vaneck is operating at the current time. Most of Biotech Vaneck's value examination focuses on studying past and present price action to predict the probability of Biotech Vaneck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biotech Vaneck's price. Additionally, you may evaluate how the addition of Biotech Vaneck to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
The market value of Biotech Vaneck ETF is measured differently than its book value, which is the value of Biotech that is recorded on the company's balance sheet. Investors also form their own opinion of Biotech Vaneck's value that differs from its market value or its book value, called intrinsic value, which is Biotech Vaneck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotech Vaneck's market value can be influenced by many factors that don't directly affect Biotech Vaneck ETF underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotech Vaneck's value and its price as these two are different measures arrived at by different means. Investors typically determine Biotech Vaneck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotech Vaneck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.